PROteolysis Targeting Chimera (PROTAC) Market Report

China PROteolysis Targeting Chimera (PROTAC) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 20, 2023
  • PAGES：149
  • REPORT CODE：GMM1745154
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the PROteolysis Targeting Chimera (PROTAC) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Merck

    • Cullgen

    • C4 Therapeutics

    • Bayer

    • Pfizer

    • Arvinas

    • Genentech

    • AstraZeneca

    • Amgen

    By Type:

    • KYM-001

    • ARV-471

    • ARV-110

    • Others

    By Application:

    • Oncology

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China PROteolysis Targeting Chimera (PROTAC) Market Overview 2018-2029

    • 1.1 China PROteolysis Targeting Chimera (PROTAC) Industry Development Overview

    • 1.2 China PROteolysis Targeting Chimera (PROTAC) Industry Development History

    • 1.3 China PROteolysis Targeting Chimera (PROTAC) Industry Market Size (2018-2029)

    • 1.4 China PROteolysis Targeting Chimera (PROTAC) Market Analysis by Type from Production Side

      • 1.4.1 China PROteolysis Targeting Chimera (PROTAC) Production Volume, Production Value and Growth Rate of KYM-001 (2018-2029)

      • 1.4.2 China PROteolysis Targeting Chimera (PROTAC) Production Volume, Production Value and Growth Rate of ARV-471 (2018-2029)

      • 1.4.3 China PROteolysis Targeting Chimera (PROTAC) Production Volume, Production Value and Growth Rate of ARV-110 (2018-2029)

      • 1.4.4 China PROteolysis Targeting Chimera (PROTAC) Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China PROteolysis Targeting Chimera (PROTAC) Market Analysis by Application from Consumption End

      • 1.5.1 China PROteolysis Targeting Chimera (PROTAC) Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.2 China PROteolysis Targeting Chimera (PROTAC) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China PROteolysis Targeting Chimera (PROTAC) Market Analysis by Region

      • 1.6.1 North China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

    Chapter 2 China PROteolysis Targeting Chimera (PROTAC) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on PROteolysis Targeting Chimera (PROTAC) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China PROteolysis Targeting Chimera (PROTAC) Market Status and Competition Analysis in 2023

      • 2.2.3 China PROteolysis Targeting Chimera (PROTAC) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China PROteolysis Targeting Chimera (PROTAC) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on PROteolysis Targeting Chimera (PROTAC) Industry Development

    Chapter 3 PROteolysis Targeting Chimera (PROTAC)Industry Chain Analysis

    • 3.1 PROteolysis Targeting Chimera (PROTAC) Industry Chain

    • 3.2 PROteolysis Targeting Chimera (PROTAC) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the PROteolysis Targeting Chimera (PROTAC) Market

    • 3.3 PROteolysis Targeting Chimera (PROTAC) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the PROteolysis Targeting Chimera (PROTAC) Market

    Chapter 4 China PROteolysis Targeting Chimera (PROTAC) Market, by Type

    • 4.1 China PROteolysis Targeting Chimera (PROTAC) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China PROteolysis Targeting Chimera (PROTAC) Total Production Volume and Growth Rate from Production Side

    • 4.5 China PROteolysis Targeting Chimera (PROTAC) Production Volume and Growth Rate, by Type

      • 4.5.1 China PROteolysis Targeting Chimera (PROTAC) Production Volume and Growth Rate of KYM-001

      • 4.5.2 China PROteolysis Targeting Chimera (PROTAC) Production Volume and Growth Rate of ARV-471

      • 4.5.3 China PROteolysis Targeting Chimera (PROTAC) Production Volume and Growth Rate of ARV-110

      • 4.5.4 China PROteolysis Targeting Chimera (PROTAC) Production Volume and Growth Rate of Others

    Chapter 5 China PROteolysis Targeting Chimera (PROTAC) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China PROteolysis Targeting Chimera (PROTAC) Total Market Size and Growth Rate from Consumption End

    • 5.5 China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate, by Application

      • 5.5.1 China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate of Oncology

      • 5.5.2 China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate of Others

    Chapter 6 China PROteolysis Targeting Chimera (PROTAC) Market, by Region

    • 6.1 China PROteolysis Targeting Chimera (PROTAC) Production Volume and Production Value, by Region

    • 6.2 China PROteolysis Targeting Chimera (PROTAC) Sales Volume and Sales Value, by Region

    Chapter 7 North China PROteolysis Targeting Chimera (PROTAC) Market Analysis

    • 7.1 North China PROteolysis Targeting Chimera (PROTAC) Market, by Type

    • 7.2 North China PROteolysis Targeting Chimera (PROTAC) Market, by Application

    Chapter 8 Central China PROteolysis Targeting Chimera (PROTAC) Market Analysis

    • 8.1 Central China PROteolysis Targeting Chimera (PROTAC) Market, by Type

    • 8.2 Central China PROteolysis Targeting Chimera (PROTAC) Market, by Application

    Chapter 9 South China PROteolysis Targeting Chimera (PROTAC) Market Analysis

    • 9.1 South China PROteolysis Targeting Chimera (PROTAC) Market, by Type

    • 9.2 South China PROteolysis Targeting Chimera (PROTAC) Market, by Application

    Chapter 10 East China PROteolysis Targeting Chimera (PROTAC) Market Analysis

    • 10.1 East China PROteolysis Targeting Chimera (PROTAC) Market, by Type

    • 10.2 East China PROteolysis Targeting Chimera (PROTAC) Market, by Application

    Chapter 11 Northeast China PROteolysis Targeting Chimera (PROTAC) Market Analysis

    • 11.1 Northeast China PROteolysis Targeting Chimera (PROTAC) Market, by Type

    • 11.2 Northeast China PROteolysis Targeting Chimera (PROTAC) Market, by Application

    Chapter 12 Southwest China PROteolysis Targeting Chimera (PROTAC) Market Analysis

    • 12.1 Southwest China PROteolysis Targeting Chimera (PROTAC) Market, by Type

    • 12.2 Southwest China PROteolysis Targeting Chimera (PROTAC) Market, by Application

    Chapter 13 Northwest China PROteolysis Targeting Chimera (PROTAC) Market Analysis

    • 13.1 Northwest China PROteolysis Targeting Chimera (PROTAC) Market, by Type

    • 13.2 Northwest China PROteolysis Targeting Chimera (PROTAC) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Merck

        • 14.1.1 Merck Company Profile

        • 14.1.2 Merck PROteolysis Targeting Chimera (PROTAC) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Cullgen

        • 14.2.1 Cullgen Company Profile

        • 14.2.2 Cullgen PROteolysis Targeting Chimera (PROTAC) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 C4 Therapeutics

        • 14.3.1 C4 Therapeutics Company Profile

        • 14.3.2 C4 Therapeutics PROteolysis Targeting Chimera (PROTAC) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bayer

        • 14.4.1 Bayer Company Profile

        • 14.4.2 Bayer PROteolysis Targeting Chimera (PROTAC) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Pfizer

        • 14.5.1 Pfizer Company Profile

        • 14.5.2 Pfizer PROteolysis Targeting Chimera (PROTAC) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Arvinas

        • 14.6.1 Arvinas Company Profile

        • 14.6.2 Arvinas PROteolysis Targeting Chimera (PROTAC) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Genentech

        • 14.7.1 Genentech Company Profile

        • 14.7.2 Genentech PROteolysis Targeting Chimera (PROTAC) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AstraZeneca

        • 14.8.1 AstraZeneca Company Profile

        • 14.8.2 AstraZeneca PROteolysis Targeting Chimera (PROTAC) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Amgen

        • 14.9.1 Amgen Company Profile

        • 14.9.2 Amgen PROteolysis Targeting Chimera (PROTAC) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 PROteolysis Targeting Chimera (PROTAC) Industry Research Conclusions

    • 15.2 PROteolysis Targeting Chimera (PROTAC) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China PROteolysis Targeting Chimera (PROTAC) Industry Market Size (2018-2029)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Production Volume, Production Value and Growth Rate of KYM-001 (2018-2029)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Production Volume, Production Value and Growth Rate of ARV-471 (2018-2029)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Production Volume, Production Value and Growth Rate of ARV-110 (2018-2029)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

    • Figure Central China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

    • Figure South China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

    • Figure East China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate from 2018-2029

    • Figure PROteolysis Targeting Chimera (PROTAC) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China PROteolysis Targeting Chimera (PROTAC) Market Share by Type in 2018

    • Figure China PROteolysis Targeting Chimera (PROTAC) Market Share by Type in 2023

    • Figure China PROteolysis Targeting Chimera (PROTAC) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Production Volume and Growth Rate of KYM-001 (2018-2023)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Production Volume and Growth Rate of ARV-471 (2018-2023)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Production Volume and Growth Rate of ARV-110 (2018-2023)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Production Volume and Growth Rate of Others (2018-2023)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Market Share by Application in 2018

    • Figure China PROteolysis Targeting Chimera (PROTAC) Market Share by Application in 2023

    • Figure China PROteolysis Targeting Chimera (PROTAC) Total Market Size and Growth Rate from Consumption End

    • Figure China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Market Size and Growth Rate of Others (2018-2023)

    • Table China PROteolysis Targeting Chimera (PROTAC) Production Volume by Region (2018-2023)

    • Table China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Region (2018-2023)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Region (2018-2023)

    • Table China PROteolysis Targeting Chimera (PROTAC) Production Value by Region (2018-2023)

    • Table China PROteolysis Targeting Chimera (PROTAC) Production Value Share by Region (2018-2023)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Production Value Share by Region (2018-2023)

    • Table China PROteolysis Targeting Chimera (PROTAC) Sales Volume by Region (2018-2023)

    • Table China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Region (2018-2023)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Region (2018-2023)

    • Table China PROteolysis Targeting Chimera (PROTAC) Sales Value by Region (2018-2023)

    • Table China PROteolysis Targeting Chimera (PROTAC) Sales Value Share by Region (2018-2023)

    • Figure China PROteolysis Targeting Chimera (PROTAC) Sales Value Share by Region (2018-2023)

    • Table North China PROteolysis Targeting Chimera (PROTAC) Production Volume by Type (2018-2023)

    • Table North China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Figure North China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Table North China PROteolysis Targeting Chimera (PROTAC) Sales Volume by Application (2018-2023)

    • Table North China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Figure North China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Table Central China PROteolysis Targeting Chimera (PROTAC) Production Volume by Type (2018-2023)

    • Table Central China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Figure Central China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Table Central China PROteolysis Targeting Chimera (PROTAC) Sales Volume by Application (2018-2023)

    • Table Central China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Figure Central China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Table South China PROteolysis Targeting Chimera (PROTAC) Production Volume by Type (2018-2023)

    • Table South China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Figure South China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Table South China PROteolysis Targeting Chimera (PROTAC) Sales Volume by Application (2018-2023)

    • Table South China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Figure South China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Table East China PROteolysis Targeting Chimera (PROTAC) Production Volume by Type (2018-2023)

    • Table East China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Figure East China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Table East China PROteolysis Targeting Chimera (PROTAC) Sales Volume by Application (2018-2023)

    • Table East China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Figure East China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Table Northeast China PROteolysis Targeting Chimera (PROTAC) Production Volume by Type (2018-2023)

    • Table Northeast China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Figure Northeast China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Table Northeast China PROteolysis Targeting Chimera (PROTAC) Sales Volume by Application (2018-2023)

    • Table Northeast China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Table Southwest China PROteolysis Targeting Chimera (PROTAC) Production Volume by Type (2018-2023)

    • Table Southwest China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Figure Southwest China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Table Southwest China PROteolysis Targeting Chimera (PROTAC) Sales Volume by Application (2018-2023)

    • Table Southwest China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Table Northwest China PROteolysis Targeting Chimera (PROTAC) Production Volume by Type (2018-2023)

    • Table Northwest China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Figure Northwest China PROteolysis Targeting Chimera (PROTAC) Production Volume Share by Type (2018-2023)

    • Table Northwest China PROteolysis Targeting Chimera (PROTAC) Sales Volume by Application (2018-2023)

    • Table Northwest China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China PROteolysis Targeting Chimera (PROTAC) Sales Volume Share by Application (2018-2023)

    • Table Merck Company Profile

    • Table Merck PROteolysis Targeting Chimera (PROTAC) Revenue, Price and Gross (2018-2023)

    • Table Cullgen Company Profile

    • Table Cullgen PROteolysis Targeting Chimera (PROTAC) Revenue, Price and Gross (2018-2023)

    • Table C4 Therapeutics Company Profile

    • Table C4 Therapeutics PROteolysis Targeting Chimera (PROTAC) Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer PROteolysis Targeting Chimera (PROTAC) Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer PROteolysis Targeting Chimera (PROTAC) Revenue, Price and Gross (2018-2023)

    • Table Arvinas Company Profile

    • Table Arvinas PROteolysis Targeting Chimera (PROTAC) Revenue, Price and Gross (2018-2023)

    • Table Genentech Company Profile

    • Table Genentech PROteolysis Targeting Chimera (PROTAC) Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca PROteolysis Targeting Chimera (PROTAC) Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen PROteolysis Targeting Chimera (PROTAC) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US